ArticleJournal of clinical pharmacology2019

Population Pharmacokinetic Analyses and Model Validation of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease.

Shankar Lanke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.